Companion Diagnostic Services from Tepnel

| October 5, 2015

article image
Tepnel offers a front-to-end companion diagnostic service - from biomarker discovery to manufactured kit. Simple and flexible fee for service approach – with no upfront costs.

Spotlight

Compliant Healthcare Technologies, LLC (CHT)

CHT is the national leader in helping hospital systems achieve Joint Commission compliance. We give hospitals the power to evaluate the current status of their piped medical gas system, from source to outlet, at any time. Whether it be medical piped gas system services and components, verification, ASSE Certification Courses, environmental services, passive dosimeter badges, construction service. we cover the gamut of services and support for medical piped gas systems and environmental services.

OTHER ARTICLES

Coronavirus Pandemic Brings Hundreds Of U.S. Clinical Trials To A Halt

Article | April 11, 2020

Rene Roach fired off a quick email in late March for an update on a colorectal cancer clinical trial for which she hoped to qualify. Worried about the coronavirus, she asked, almost as an afterthought, whether the study had been put on hold because of the pandemic.The answer crushed her: It had been. "That's when COVID-19 shut down everything," says Roach, 50, of Germantown, Md. Roach assumed that there would be workarounds for patients like her, who have stage IV cancer. These patients often depend on clinical trials as their best chance to knock cancer out when other therapies have failed. For now, she's being treated with traditional chemotherapy, but she was counting on the drug cocktail from the clinical trial. She figures if chemo was going to rid her body of cancer for good, it would have done so already.

Read More

Clinical Development Risks and Issues in a COVID-19 World

Article | April 11, 2020

Global clinical guidelines have shifted the industry toward risk-based approaches for the planning and execution of clinical trials. The ICH’s guidelines for Good Clinical Practice state that sponsors should evaluate identified risks against existing risk controls by considering “the likelihood of errors occurring, the extent to which such errors would be detectable, and the impact of such errors on human subject protection and reliability of trial results” (ICH E6 R2).

Read More

Comparing HydroxyChloroquine Trials

Article | April 11, 2020

One minor side effect of the pandemic is that perhaps more people will learn about what drug research and clinical trials can really be like. Today’s example: we have a clinical trial of hydroxychloroquine from Wuhan that has just published on a preprint server. What’s good is that this one is blinded, randomized, and controlled (like the earlier hydroxychloroquine which one I blogged about here from Zhejiang University, so we can actually talk about it rather than just spend all our time wondering what the heck is going on.

Read More

Decentralized Clinical Trials: Imperative for Pharma Sector to fight COVID19

Article | April 11, 2020

These are unprecedented times. The world is mobbed by a contagion virus, putting people’s health at risk, threatening to destabilize economies. It has already put global healthcare systems under tremendous pressures, and managed to resist efforts to contain it. Even though coronaviruses are not new, this COVID-19 strain has created panic and forced us to be locked down in our homes sans any movement for weeks, if not months. Organizations are fighting an intense battle to keep their workforce safe, minimize risk, and ensure business continuity. For the Life Sciences industry, however, the challenge is even more significant. The whole world is looking at them to come up with a vaccine and a cure. But that is easier said than done. Bringing a new drug to market is an uphill battle and requires rigorous clinical trials. This process already has regulatory challenges. With the current lockdown situation, the Pharma community is grappled with the challenge of continuing some of the critical and time-sensitive in-flight trials so that their regulatory submission, registration, and market entry are not impacted. But all may not be lost. With the right technology solution, it is possible to turn the situation around rapidly.

Read More

Spotlight

Compliant Healthcare Technologies, LLC (CHT)

CHT is the national leader in helping hospital systems achieve Joint Commission compliance. We give hospitals the power to evaluate the current status of their piped medical gas system, from source to outlet, at any time. Whether it be medical piped gas system services and components, verification, ASSE Certification Courses, environmental services, passive dosimeter badges, construction service. we cover the gamut of services and support for medical piped gas systems and environmental services.

Events